510(k) K221968
K221968 is an FDA 510(k) premarket notification submitted by Biomet, Inc. for the device "StageOne Shoulder Cement Spacer Molds". The FDA issued a decision of Substantially Equivalent on Sep 15, 2022. The device falls under product code MBB (Bone Cement, Antibiotic), a Class II device regulated under 21 CFR 888.3027. Biomet, Inc. has 443 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 15, 2022
- Date Received
- Jul 5, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Bone Cement, Antibiotic
- Device Class
- Class II
- Regulation Number
- 888.3027
- Review Panel
- OR
- Submission Type
- 510(k)
Need the full FDA record for Biomet, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.